Literature DB >> 18220706

The immune system and murine atherosclerosis.

Godfrey S Getz1, Paul A Vanderlaan, Catherine A Reardon.   

Abstract

In this review the modulation of lipoprotein metabolism and atherogenesis by the innate and adaptive immune systems of the mouse is discussed. While recognizing the participation of all components of the immune system in atherogenesis, it is clear that robust atherogenesis may proceed without an adaptive immune response. But even when all components are active, the outcome reflects a balance between pro- and anti-inflammatory reactants and cells. This network of interactions is summarized in this review and is complemented by other reviews in this series. Also noted is the differential response of different vascular beds following manipulation of the components of the adaptive immune system. Further work is required to achieve a fuller understanding of the role of these systems in atherogenesis, especially with the prospect of favorably modulating atherogenesis by the manipulation of the participating immune components as for example in a vaccination approach.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220706     DOI: 10.2174/138945007783220669

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  6 in total

Review 1.  Natural killer T cells in lipoprotein metabolism and atherosclerosis.

Authors:  G S Getz; P A Vanderlaan; C A Reardon
Journal:  Thromb Haemost       Date:  2011-09-22       Impact factor: 5.249

2.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

3.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.

Authors:  Meng-Yun Chou; Linda Fogelstrand; Karsten Hartvigsen; Lotte F Hansen; Douglas Woelkers; Peter X Shaw; Jeomil Choi; Thomas Perkmann; Fredrik Bäckhed; Yury I Miller; Sohvi Hörkkö; Maripat Corr; Joseph L Witztum; Christoph J Binder
Journal:  J Clin Invest       Date:  2009-04-13       Impact factor: 14.808

4.  Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Inflamm Res       Date:  2011-06-02

5.  Rheumatoid factor, anti-nuclear antibody in ischemic heart disease: Acute versus chronic patients.

Authors:  Akram Sedaghat; Masoumeh Sadeghi; Ramin Heidari; Efat Sistani; Zahra Bayanfar
Journal:  ARYA Atheroscler       Date:  2014-11

6.  Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Veneracion G Cabana; Chyung-Ru Wang; Godfrey S Getz
Journal:  Int J Mol Sci       Date:  2019-09-14       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.